{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:23:46Z","timestamp":1792715026093,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001960","name":"American Society for Radiation Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001960","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.prro.2023.01.005","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T19:19:11Z","timestamp":1681845551000},"page":"195-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["ASTRO Radiation Therapy Summary of the ASCO Guideline on Management of Stage III Non-Small Cell Lung Cancer"],"prefix":"10.1016","volume":"13","author":[{"suffix":"II","given":"Charles B.","family":"Simone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen B.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford G.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.M.","family":"Videtic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7174-4280","authenticated-orcid":false,"given":"George","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2023.01.005_bib0001","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.21.02528","article-title":"Management of stage III non-small-cell lung cancer: ASCO guideline","volume":"40","author":"Daly","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0002","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.athoracsur.2003.11.021","article-title":"Gender differences in non-small-cell lung cancer survival: An analysis of 4,618 patients diagnosed between 1997 and 2002","volume":"78","author":"Visbal","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.prro.2023.01.005_bib0003","first-page":"299","article-title":"Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review","volume":"71","author":"Sosa","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.prro.2023.01.005_bib0004","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cllc.2019.02.015","article-title":"Patterns of care and survival in stage III NSCLC among Black and Latino patients compared with White patients","volume":"20","author":"Vyfhuis","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.prro.2023.01.005_bib0005","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/j.cllc.2019.08.009","article-title":"Insurance status is an independent predictor of overall survival in patients with stage III non-small-cell lung cancer treated with curative intent","volume":"21","author":"Rice","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.prro.2023.01.005_bib0006","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.prro.2015.02.012","article-title":"Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline","volume":"5","author":"Rodrigues","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0007","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(13)62159-5","article-title":"Preoperative chemotherapy for non-small-cell lung cancer: A systematic review and meta-analysis of individual participant data","volume":"383","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2023.01.005_bib0008","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2023.01.005_bib0009","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1470-2045(08)70156-6","article-title":"Effect of preoperative chemoradiation in addition to preoperative chemotherapy: A randomised trial in stage III non-small-cell lung cancer","volume":"93","author":"Thomas","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0010","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(15)60294-X","article-title":"Induction chemoradiation in stage IIIA\/N2 non-small-cell lung cancer: A phase 3 randomised trial","volume":"386","author":"Pless","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2023.01.005_bib0011","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ejcts.2008.12.029","article-title":"Pulmonary resection after concurrent chemotherapy and high dose (60 Gy) radiation for non-small cell lung cancer is safe and may provide increased survival","volume":"35","author":"Cerfolio","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.prro.2023.01.005_bib0012","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jtcvs.2020.03.171","article-title":"Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancer","volume":"160","author":"Donington","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.prro.2023.01.005_bib0013","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.athoracsur.2004.04.085","article-title":"Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer","volume":"78","author":"Sonett","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.prro.2023.01.005_bib0014","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.adro.2017.07.009","article-title":"Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (\u226560 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer","volume":"2","author":"Vyfhuis","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0015","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Auperin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0016","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/JTO.0b013e3182429682","article-title":"Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma","volume":"7","author":"Machtay","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0017","first-page":"242","article-title":"Recurrence after surgery in patients with NSCLC","volume":"3","author":"Uramoto","year":"2014","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.prro.2023.01.005_bib0018","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(98)06341-7","article-title":"Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.prro.2023.01.005_bib0019","article-title":"Postoperative radiotherapy for non-small cell lung cancer","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prro.2023.01.005_bib0020","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/S0140-6736(05)60774-X","article-title":"Postoperative radiotherapy in non-small-cell lung cancer","volume":"352","author":"Machtay","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2023.01.005_bib0021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2013.08.011","article-title":"Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis","volume":"110","author":"Billiet","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0022","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1200\/JCO.2005.04.6110","article-title":"Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database","volume":"24","author":"Lally","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0023","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1200\/JCO.2014.58.5380","article-title":"Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: A review of the National Cancer Data Base","volume":"33","author":"Robinson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0024","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ijrobp.2008.01.044","volume":"72","author":"Douillard","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2023.01.005_bib0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1470-2045(21)00606-9","article-title":"Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): An open-label, randomised, phase 3 trial","volume":"23","author":"Le Pechoux","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2020.08.2280","volume":"31","author":"Le Pechoux","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0027","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaoncol.2021.1910","article-title":"Effect of postoperative radiotherapy for patients with pIIIA-N2 non-small cell lung cancer after complete resection and adjuvant chemotherapy: The phase 3 PORT-C randomized clinical trial","volume":"7","author":"Hui","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0028","doi-asserted-by":"crossref","first-page":"e745","DOI":"10.1016\/j.cllc.2021.02.002","article-title":"Single institution experience of proton and photon-based postoperative radiation therapy for non-small-cell lung cancer","volume":"22","author":"Boyce-Fappiano","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.prro.2023.01.005_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.cllc.2016.12.009","article-title":"First clinical report of proton beam therapy for postoperative radiotherapy for non-small-cell lung cancer","volume":"18","author":"Remick","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.prro.2023.01.005_bib0030","article-title":"Increasing heart dose reduces overall survival in patients undergoing postoperative radiation therapy for NSCLC","volume":"2","author":"Shepherd","year":"2021","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.prro.2023.01.005_bib0031","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijrobp.2022.02.014","article-title":"Effects of tumor mutational burden and gene alterations associated with radiation response on outcomes of postoperative radiation therapy in non-small cell lung cancer","volume":"113","author":"Shaverdian","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2023.01.005_bib0032","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13014-016-0640-8","article-title":"Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: Phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC","volume":"11","author":"Giaddui","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0033","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jamaoncol.2021.3186","article-title":"Accelerated hypofractionated image-guided vs conventional radiotherapy for patients with stage II\/III non-small cell lung cancer and poor performance status: A randomized clinical trial","volume":"7","author":"Iyengar","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0034","doi-asserted-by":"crossref","first-page":"254","DOI":"10.6004\/jnccn.2021.0013","article-title":"NCCN guidelines insights: Non-small cell lung cancer, version 2.2021","volume":"19","author":"Ettinger","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.prro.2023.01.005_bib0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1200\/JCO.2016.69.1378","article-title":"Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: A secondary analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial","volume":"35","author":"Chun","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0036","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaoncol.2015.3969","article-title":"Quality of life analysis of a radiation dose-escalation study of patients with non-small-cell lung cancer: A secondary analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial","volume":"2","author":"Movsas","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2023.01.005_bib0037","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1200\/JCO.2017.74.0720","article-title":"Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-cell lung cancer","volume":"36","author":"Liao","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187985002300005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187985002300005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:26:08Z","timestamp":1761819968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187985002300005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S187985002300005X"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2023.01.005","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ASTRO Radiation Therapy Summary of the ASCO Guideline on Management of Stage III Non-Small Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2023.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}